Acticor Biotech



Acticor Biotech is a spin-off from Inserm (French National Institute of Health and Medical Research) dedicated to the development of an innovative therapeutic strategy for a safe and effective emergency treatment of ischemic strokes which account for 80% of all strokes. Acticor Biotech’s project stems from the sheer need for new therapeutic options to manage stroke.

Sophie Binay
General Manager & Chief Scientific Officer
Nacera Brouttelande
Office Manager
Vanessa Clatot
Clinical Trial Lead
Eric Cohen
Chief Financial Officer
Andrea Comenducci
Medical Director
Olivier Favre-Bulle
CMC Adviser
Aymeric Humblot
Head of Finance & Administration
Jessica Jami
Regulatory Affairs Manager
Laurie Jullien
Head of Regulatory Affairs
Angéla La
Pharmaceutical Development Manager
Marilyn Labart
Senior Clinical Project Manager
Antoine Lebel
Communication & IT Assistant
Kristell Lebozec
Head of Pharmaceutical & Non-Clinical Development
Adeline Meilhoc
Global Clinical Operations Director
Pauline Ferlan
Analytical Project Manager
Stéphanie Paul
Clinical Operations Trainer
Yannick Plétan
Chief Medical Officer & General Manager
Victoria Rutman
Head of Quality Assurance
Anouar Sari
Senior Clinical Project Manager
Elie Toledano
Head of Global Project Coordination

No teams yet!

No jobs yet!

No wires yet!

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.